CHLORZOXAZONE Drug Patent Profile
✉ Email this page to a colleague
When do Chlorzoxazone patents expire, and when can generic versions of Chlorzoxazone launch?
Chlorzoxazone is a drug marketed by Acme Labs, Actavis Elizabeth, Aptapharma Inc, Aurobindo Pharma Ltd, Barr, Belcher, Corepharma, Dr Reddys Labs Sa, Glenmark Pharms Ltd, Graviti Pharms, Havix, Mikart, Novitium Pharma, Ohm Labs, Par Pharm Inc, Pioneer Pharms, Rise Pharma, Rising, Strides Pharma, Sun Pharm Industries, Teva Pharms Usa Inc, Upsher Smith Labs, and Watson Labs. and is included in thirty-five NDAs.
The generic ingredient in CHLORZOXAZONE is chlorzoxazone. There are sixteen drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the chlorzoxazone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Chlorzoxazone
A generic version of CHLORZOXAZONE was approved as chlorzoxazone by AUROBINDO PHARMA LTD on May 4th, 1988.
Summary for CHLORZOXAZONE
US Patents: | 0 |
Applicants: | 23 |
NDAs: | 35 |
Finished Product Suppliers / Packagers: | 25 |
Raw Ingredient (Bulk) Api Vendors: | 137 |
Clinical Trials: | 10 |
Patent Applications: | 3,691 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for CHLORZOXAZONE |
DailyMed Link: | CHLORZOXAZONE at DailyMed |
Recent Clinical Trials for CHLORZOXAZONE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Texas Southwestern Medical Center | Phase 1 |
Tufts University | Phase 1 |
The Institute of Molecular and Translational Medicine, Czech Republic | Phase 2 |
Pharmacology for CHLORZOXAZONE
Drug Class | Muscle Relaxant |
Physiological Effect | Centrally-mediated Muscle Relaxation |
Medical Subject Heading (MeSH) Categories for CHLORZOXAZONE
Anatomical Therapeutic Chemical (ATC) Classes for CHLORZOXAZONE
US Patents and Regulatory Information for CHLORZOXAZONE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva Pharms Usa Inc | CHLORZOXAZONE | chlorzoxazone | TABLET;ORAL | 212898-001 | Jun 17, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Pioneer Pharms | CHLORZOXAZONE | chlorzoxazone | TABLET;ORAL | 089592-001 | Jan 6, 1989 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Watson Labs | CHLORZOXAZONE | chlorzoxazone | TABLET;ORAL | 081040-001 | Aug 22, 1989 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Watson Labs | CHLORZOXAZONE | chlorzoxazone | TABLET;ORAL | 086901-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |